PrEP
Apr 27, 2026 | News
When the COVID-19 brought the world to a standstill in 2020, health systems across low- and middle-income countries faced unprecedented stresses. Clinics closed. Supply chains faltered. Patients missed appointments. Laboratory systems stalled. At the very moment when...
Oct 23, 2025 | In the Media, News
ICAP’s founder and global director appears on The Threshold, the new podcast from Foreign Policy about the fight to end infectious diseases around the world and the innovations that could get us there. In this episode, Dr. El-Sadr recounts the history of the...
Oct 14, 2025 | Events
In the ongoing quest to reach a world without AIDS, the development of the groundbreaking new HIV prevention drug, Lenacapavir, offers incredible promise. The longacting twice-yearly injection provides a highly effective alternative to daily pills and other options,...
Jul 29, 2025 | News
Pre-exposure prophylaxis (PrEP) is a highly effective HIV prevention tool, including for prevention of vertical transmission of HIV from mother to child. However, in the Democratic Republic of Congo (DRC), promotion of oral PrEP among pregnant women is low. In the...
Mar 3, 2025 | In the Media
“Tailoring strategies to address the unique needs of this population is critical to addressing this challenge,” said ICAP’s Wafaa El-Sadr.